Schwandt P
II. Medizinische Klinik, Klinikum Grosshadern, Universität, Mäuchen.
Klin Wochenschr. 1990;68 Suppl 22:54-8.
There is more and more epidemiological evidence elevated plasma triglyceride concentrations increase the risk for atherosclerosis especially for coronary heart disease. Since triglyceride-rich lipoprotein fractions also contain different concentrations of cholesterol and since the metabolism of triglyceride-rich lipoproteins is not independent from the metabolism of HDL, the variables HDL-cholesterol and LDL-cholesterol (respectively total-cholesterol) must be taken into account when evaluating the atherosclerotic risk of triglyceride-rich lipoproteins. This epidemiological evidence is underlined by clinical observations about the high incidence of atherosclerosis and coronary heart disease in relation to abnormalities in the triglyceride-rich lipoprotein metabolism as in patients with diabetes mellitus, familial dysbetalipoproteinemia and familial combined hyperlipidemia. Very low density lipoproteins (VLDL), low density lipoproteins (LDL) and high density lipoproteins (HDL) from patients with hypertriglyceridemia are enriched in free and esterified cholesterol. This changed composition of these lipoprotein fractions leads to an increased elimination from the circulation via atherogenic macrophages and smooth muscles cell pathways. Successful treatment of hypertriglyceridemic states obviously normalizes the changed composition of the lipoprotein fractions and in consequence effects also the atherogenicity.
越来越多的流行病学证据表明,血浆甘油三酯浓度升高会增加动脉粥样硬化的风险,尤其是冠心病的风险。由于富含甘油三酯的脂蛋白组分也含有不同浓度的胆固醇,并且由于富含甘油三酯的脂蛋白的代谢并非独立于高密度脂蛋白的代谢,因此在评估富含甘油三酯的脂蛋白的动脉粥样硬化风险时,必须考虑高密度脂蛋白胆固醇和低密度脂蛋白胆固醇(分别为总胆固醇)这两个变量。关于动脉粥样硬化和冠心病的高发病率与富含甘油三酯的脂蛋白代谢异常有关的临床观察结果,如糖尿病、家族性异常β脂蛋白血症和家族性混合性高脂血症患者,进一步证实了这一流行病学证据。高甘油三酯血症患者的极低密度脂蛋白(VLDL)、低密度脂蛋白(LDL)和高密度脂蛋白(HDL)富含游离胆固醇和酯化胆固醇。这些脂蛋白组分组成的改变导致通过致动脉粥样硬化的巨噬细胞和平滑肌细胞途径从循环中清除增加。成功治疗高甘油三酯血症状态显然会使脂蛋白组分的改变组成正常化,从而也会影响其致动脉粥样硬化性。